Previous Hold Today ACAD ranks #1736 as HOLD CANDIDATE #1736 Next Hold

ACAD stock forecast ACADIA Pharmaceuticals Inc.

ACAD stock forecast

Thursday May 23, 2019 Change 0.80% Price $25.34
Chart period: 2019-02-25 - 2019-05-23
VOLUME
Buy
TREND
Sell
MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Social Sentiment for ACAD

Today's data is from 2 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
100%
0%
Weighted Sentiment 0.00

Will ACAD stock price go up or down on Tue, 28 May 2019?

Predict

ACADIA Pharmaceuticals Inc. Forecast and Stock Analysis

Technical ACAD stock analysis for Thursday May 23, 2019.

Hold candidate since 2019-05-23
Shorts n/a
Insider % n/a
Institutional % n/a
Beta 1.96
ROA -67.30%
Price to book USD 8.66
P/E Ratio -12.30
Next Earnings Date 2019-08-04


ACADIA Pharmaceuticals Inc. gained 0.80% in the last trading day ( Thursday, 23rd May 2019 ), rising from $25.14 to $25.34 During day the stock fluctuated 5.70% from a day low at $24.03 to a day high of $25.40. The price has fallen in 6 of the last 10 days and is down by -2.46% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 0.48 million more shares were traded than the day before. In total, 1.05 million shares bought and sold for approximately $26.71 million.

Quick summary:

  • 30 day high of the ACAD stock price was $26.86 and low was $23.19.
  • 90 day high was $28.67 and low was $22.13.
  • 52 week high for the ACADIA Pharmaceuticals Inc. - $28.67 and low - $12.77.

Trend

ACADIA Pharmaceuticals Inc. lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.27% during the next 3 months and, with 90% probability hold a price between $21.85 and $26.29 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. ACADIA Pharmaceuticals Inc. holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $25.41. On a fall, the stock will find some support from the short-term average at $25.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 43 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $23.58 and $23.56.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ACADIA Pharmaceuticals Inc. finds support just below today's level at $23.58. If this is broken, then the next support from accumulated volume will be at $23.56 and $23.32.

Support: $23.58 Price: $25.34 Resistance: $25.50

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.37 (5.70%) between high and low. For the last week, the stock has had a daily average volatility of 3.97%.

Our recommended stoploss: $23.76 (-6.23%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

3.97 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

ACADIA Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded
Previous Hold Today ACAD ranks #1736 as HOLD CANDIDATE #1736 Next Hold
ACAD $25.34 ($0.20 0.80%)
ACAD is up $0.20 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for ACAD based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the ACAD analysis is free »

Will ACAD stock price go up or down
on Tue, 28 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank